Breast Cancer, Brunner and Suddarth, Chapter 52 Breast Assessment,…
Question Answered step-by-step Breast Cancer, Brunner and Suddarth, Chapter 52 Breast Assessment,… Breast Cancer, Brunner and Suddarth, Chapter 52Breast Assessment, pp 1709-1718 Malignant Conditions of the Breast, pp 1719-1730 Nursing Management, pp 1731-1734Charts/Tables/Figures:Chart 52-1, Abnormal Assessment Findings During InspectionChart 52-2, BSE Patient EducationTable 52-2, Comparisons of Various Breast Masses (focus on difference between benign and malignant)Table 52-3, Risk Factors for Breast CancerChart 52-5, Hand and Arm Care after ALNDChart 52-6, Patient Education for Drainage DevicesChart 52-7, Patient Education for Arm ExercisesTable 52-5, Comparing SLNB and ALNDLearning Objective #11: Identify the risk factors and health promotion for breast cancer.Learning Objective #12: Compare and contrast the characteristics of benign and malignant breast disorders, diagnostic imaging, and surgical biopsy types for breast cancer. What are the characteristics of benign vs. malignant breast disorders?For what purpose is each diagnostic test used, includingWhat are the pre-op, immediate post-op, and discharge instructions following breast biopsy?Learning Objective #13: Use the nursing process as a framework for care of the patient undergoing surgery for the treatment of breast cancer. Differentiate between the three types of mastectomy surgical treatments and the two lymph node dissection methods.What are the assessments needed to identify post-op complications following mastectomy?What are the important patient education points to make for drain care following mastectomy?What precautions should be enforced after surgery and discharge to reduce the risk of lymphedema?Learning Objective #14: Explain the purpose, mechanism of action, side effects, and administration considerations for common breast cancer medications (pegfilgrastim, filgrastim, neupogen, tamoxifen and aromatase inhibitors). Health Science Science Nursing NURSING NURS Share QuestionEmailCopy link Comments (0)


